A quantitative promoter methylation profile of prostate cancer.
about
One-Carbon Metabolism in Prostate Cancer: The Role of Androgen SignalingDietary factors and epigenetic regulation for prostate cancer preventionCancer diagnostic classifiers based on quantitative DNA methylationRisk calculators and updated tools to select and plan a repeat biopsy for prostate cancer detectionEpigenetic modulators as therapeutic targets in prostate cancerA genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignanciesConvergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosisGSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cellsImpact of glutathione-S-transferases (GST) polymorphisms and hypermethylation of relevant genes on risk of prostate cancer biochemical recurrence: a meta-analysisAssociation of DSC3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosisExpression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumorsQuantitative methylation profiles for multiple tumor suppressor gene promoters in salivary gland tumorsThe Ras-association domain family (RASSF) members and their role in human tumourigenesis.In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors.Hypermethylation of genes for diagnosis and risk stratification of prostate cancerGenome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.Estrogen receptor-alpha methylation predicts melanoma progressionAssociation between lifestyle factors and CpG island methylation in a cancer-free population.Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples.Changes of protein expression in prostate cancer having lost its androgen sensitivity.Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells.A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detectionFolate in colorectal cancer, prostate cancer and cardiovascular disease.Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis.Aberrant DNA methylation and prostate cancer.A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex.Epigenetics in prostate cancer.DNA Methylation and Flavonoids in Genitourinary Cancers.DNA methylation changes in prostate cancer: current developments and future clinical implementation.Role of diet in prostate cancer: the epigenetic link.Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis.Clinical utility of RASSF1A methylation in human malignancies.AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy.Epigenetic regulation of prostate cancerTumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase.Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies.Quantitative detection of promoter hypermethylation as a biomarker of acute kidney injury during transplantation.
P2860
Q26740548-5F2A3BAF-0C64-4A20-9E62-D535D6AF0D0CQ26991774-AC178D26-1B70-434E-8DBE-37F234D23032Q27012960-16134D41-632E-49C4-A655-095ABDF3A7B8Q27027085-173AFA2C-DC74-4453-BDE8-7488893D608AQ28071912-CFC83164-CE7A-49C1-B67E-A89D0AFE70B7Q28469084-223B6BA6-C861-4F1B-AC87-49CB8EA7FE3FQ28472991-ED5B44DE-101E-4D3F-8CDD-275A203F7D10Q28477278-430086F7-5857-480D-ABDF-75E05AEE9CE6Q28533760-3281D480-8A83-4481-ACDA-532E3DBAB482Q28541425-7EE10AAA-9280-4A79-88D1-BA30C1D28E7FQ28748604-BBCFC13C-237A-4054-9018-BD82FF9F1E4FQ28751911-CD498E1B-3539-4DD7-A73C-4C0B0B878D03Q31121564-EF11574C-249C-4BF2-BCB0-B3EEA3B0FE7EQ33282538-BBDC61EC-3AE6-4F4E-90CC-0A276536F14FQ33291459-15F090BD-2602-4B8F-A825-A906E6B132C1Q33410858-4A6D3DC6-0049-46FE-9CCD-9E76EB9A4C60Q33568125-D58205F4-4C2D-448B-9386-00FE0F6B393DQ33796956-6CE83671-0C82-4E19-A052-18C79564BC72Q33797076-FB4A1AA4-F287-4058-A309-3E5A69B03F4DQ33886934-8C15D6D8-7C61-4E76-95BA-D9F85068236DQ34014559-6B3093B2-AD92-4435-B522-B8D63FADFCFBQ34043941-82D2DB2E-35F1-4C0A-A980-8CA9A0BCF677Q34228887-08AA4400-0C18-44D0-A857-C1F187383696Q34294196-2B30D457-CBAA-4BE1-BB58-22230297DA7CQ34582313-6CCD2B09-9D60-45E1-8EA1-4CB5D000C770Q35000853-94C5BFB1-4D05-4FB8-8260-05134308AE13Q35560819-F630D9EA-EB00-4412-B4A0-E2F10526E78BQ35566861-852107ED-09F3-4F1B-B005-F0A1467E9DDFQ35595690-502A2CD7-3D0A-4AE1-8FF3-68F4B373690EQ35608952-65A94144-D630-4DC3-82A0-5AD21647916BQ35623184-8D919C8C-1A95-4CE7-B93F-09734785FD70Q35636543-9FC78B1D-6FC5-4F08-858A-922C34B7448AQ35768176-254B3C61-D51B-40DB-B263-AF8D0210D257Q35790157-E631A758-273E-4613-B9D4-40031C1B14A1Q35909621-AB58115C-FD80-4D8B-AF0B-DDF72AA6BAE2Q35989658-0C2CD71D-BF36-48DA-A662-B65CE838E609Q36001910-03A8635B-9483-4C2B-9BDA-A4722D445A74Q36065002-50421D36-66E4-49DE-AE5E-CEB9285989E0Q36097736-C17FF0B0-538E-4E1D-9A7D-7F0CBF9512B1Q36102469-E5BD51A6-B0A2-478C-A916-8CB51D1FBAC9
P2860
A quantitative promoter methylation profile of prostate cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
A quantitative promoter methylation profile of prostate cancer.
@en
A quantitative promoter methylation profile of prostate cancer.
@nl
type
label
A quantitative promoter methylation profile of prostate cancer.
@en
A quantitative promoter methylation profile of prostate cancer.
@nl
prefLabel
A quantitative promoter methylation profile of prostate cancer.
@en
A quantitative promoter methylation profile of prostate cancer.
@nl
P2093
P50
P1476
A quantitative promoter methylation profile of prostate cancer.
@en
P2093
Carlos Lopes
David Sidransky
Elizabeth Mambo
Franclim R Ribeiro
Graça Varzim
Jorge Oliveira
P304
P356
10.1158/1078-0432.CCR-04-0894
P407
P577
2004-12-01T00:00:00Z